| Terminated | Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Can NCT04044430 | University of California, San Francisco | Phase 1 |
| Completed | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190 | Stanford University | N/A |
| Completed | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer NCT02728804 | SWOG Cancer Research Network | — |
| Terminated | Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Sprea NCT02110953 | Fox Chase Cancer Center | Phase 1 |
| Completed | Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer NCT02393755 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |
| Withdrawn | Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With St NCT02235324 | University of Southern California | Phase 2 |
| Completed | CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surg NCT02232152 | Wake Forest University Health Sciences | Phase 1 |
| Completed | Programs to Support You During Chemotherapy (Pro-You) NCT02148406 | Vanderbilt-Ingram Cancer Center | N/A |
| Completed | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patient NCT02041481 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Ch NCT01941173 | City of Hope Medical Center | N/A |
| Completed | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520 | City of Hope Medical Center | N/A |
| Completed | Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid NCT01987726 | Ohio State University Comprehensive Cancer Center | — |
| Completed | PET-MRI in Diagnosing Patients With Colon or Rectal Cancer NCT01807117 | Case Comprehensive Cancer Center | N/A |
| Completed | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis NCT01806675 | Sanjiv Sam Gambhir | Phase 1 / Phase 2 |
| Completed | Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or NCT01802320 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Ca NCT01729923 | University of Washington | Phase 2 |
| Completed | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors NCT01217450 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest NCT01643499 | University of Chicago | Phase 1 |
| Completed | Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Pa NCT01383343 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer NCT01365910 | Vanderbilt-Ingram Cancer Center | Phase 2 |
| Terminated | Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treati NCT01320683 | City of Hope Medical Center | Phase 2 |
| Withdrawn | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colore NCT01270438 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer NCT01198535 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors NCT01131234 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung NCT00937482 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cance NCT01637194 | Fox Chase Cancer Center | Phase 1 |
| Terminated | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Th NCT00499369 | National Cancer Institute (NCI) | Phase 3 |
| Completed | SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer NCT00103311 | National Cancer Institute (NCI) | Phase 2 |
| Completed | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Ca NCT00084643 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastati NCT00077298 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, an NCT00060411 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer NCT00005036 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer NCT00002796 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Withdrawn | Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic P NCT02575508 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |